ARCHIVES

FDA to refer false statements by regulated companies to SEC.

This article is from The Cancer Letter archive.

Vol. 30 No. 09 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

Saul Rivin Receives ACCC Clinical Research Award.

December 1, 2000

House panel examines use of grant funds.

September 23, 2005

NHIS Cancer Control Supplement To Survey 52,000

October 4, 1985

Seattle Institutions Win $16 Million In Grants For Comparative Effectiveness Research

October 16, 2009

Ford Asks NCAB for Scientific Basis For Regulation Of Tar and Nicotine Content Of Cigarettes By Dec.

October 25, 1974

$25 Million In Federal Aid to Jackson Laboratory approved By Senate; NIH, Natcher Are Opposed

August 11, 1989